Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: The Chinese University of Hong Kong Early Arthritis Study [NA]
This clinical trial update reports the completion of the Early Arthritis Study conducted by The Chinese University of Hong Kong for rheumato…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Long Term Open Label Continuation Study [Phase 3]
This update notes the completion of a long-term open-label extension study in Phase 3 for rheumatoid arthritis conducted by Abbott, with res…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers [Phase 1]
Phase 1 trial comparing safety and pharmacokinetic characteristics of Daewoong's DWP422 biosimilar to Enbrel (etanercept) in healthy male vo…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis [Phase 1]
Reports a Phase 1, single-dose study of CAM-3001 in patients with rheumatoid arthritis. The trial has completed.
-
CLINICAL_TRIALS research · 2012-07-17Clinical Trial Update: Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis
An update on a clinical trial analyzing respiratory mechanics in patients with rheumatoid arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-07-12Clinical Trial Update: Painless Synovitis in Patients With Longstanding Rheumatoid Arthritis
This clinical trial update discusses ongoing work on painless synovitis in longstanding rheumatoid arthritis patients; the current status of…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis [Phase 3]
Open-label long-term safety study of Certolizumab Pegol (CZP) in patients with rheumatoid arthritis completed; results posted in 2012.
-
FDA approval · 2012-07-09FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Original Application (BluePoint Laboratories)
FDA approved a diclofenac sodium and misoprostol product under an Original Application for BluePoint Laboratories, signaling a generic clear…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. [Phase 2]
A Phase 2 study comparing GW274150 to prednisolone in rheumatoid arthritis, given repeatedly for 28 days. The trial status is completed.
-
CLINICAL_TRIALS safety_alert · 2012-06-29Clinical Trial Update: Rituximab-induced Pulmonary Function Changes
A clinical trial update reports changes in pulmonary function associated with rituximab in patients with rheumatoid arthritis and inflammato…
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 safety and efficacy study of LymphoStat-B (belimumab) in rheumatoid arthritis completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis [Phase 4]
A completed Phase 4 trial assessed the impact of atorvastatin on rheumatoid arthritis disease activity and HDL cholesterol function.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) [Phase 3]
Open-label extension for RA patients from a dosing flexibility Phase 3 study has completed with results posted in 2012.
-
CLINICAL_TRIALS research · 2012-06-14Clinical Trial Update: Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research [NA]
Update on a clinical trial researching cycle combination therapy using disease-modifying antirheumatic drugs for rheumatoid arthritis; phase…
-
FDA approval · 2012-06-13FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., updating the product's regulatory approval.
-
CLINICAL_TRIALS research · 2012-06-12Clinical Trial Update: Orofacial Evaluation in Women With Rheumatoid Arthritis
This clinical trial update notes that a study evaluating orofacial evaluation in women with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder
An observational trial update summarizes outcomes for patients with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis who wer…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose [Phase 1]
A Phase 1 safety study of SB-681323 given as a single intravenous dose in healthy adult subjects has completed, with rheumatoid arthritis an…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: SB-681323-Methotrexate Interaction Study [Phase 1]
A Phase 1 study evaluating the interaction between SB-681323 and methotrexate in rheumatoid arthritis has completed. The study was sponsored…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Abatacept With Methotrexate- Phase IIB [Phase 2]
Phase IIb trial evaluating abatacept with methotrexate in rheumatoid arthritis has completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)
This clinical trial update reports on adherence of NSAID-treated patients to co-prescribed proton pump inhibitors in osteoarthritis, rheumat…
-
FDA approval · 2012-05-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS research · 2012-05-24Clinical Trial Update: Finding Early Rheumatoid Arthritis
This update describes a Brigham and Women's Hospital–sponsored clinical trial to identify early rheumatoid arthritis, with the trial status …
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis [Phase 3]
Open-label Phase 3 study of lumiracoxib 200 mg once daily in primary knee osteoarthritis or rheumatoid arthritis has completed.
-
CLINICAL_TRIALS withdrawal · 2012-05-21Clinical Trial Update: Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes
The clinical trial examining chemokines and proinflammatory cytokines in rheumatoid synovial pathology has been withdrawn.